Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer’s Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer’s Disease
Authors
Keywords
-
Journal
ACS Medicinal Chemistry Letters
Volume 12, Issue 9, Pages 1389-1395
Publisher
American Chemical Society (ACS)
Online
2021-08-10
DOI
10.1021/acsmedchemlett.1c00048
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification
- (2021) Nicholas J. Izzo et al. Alzheimers & Dementia
- Alzheimer’s protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity
- (2020) Colleen S. Limegrover et al. JOURNAL OF NEUROCHEMISTRY
- Systematic and standardized comparison of reported Amyloid-β receptors for sufficiency, affinity, and Alzheimer’s disease relevance
- (2019) Levi M. Smith et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
- (2018) Barbara Mroczko et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
- (2018) Erika N. Cline et al. JOURNAL OF ALZHEIMERS DISEASE
- Natural-Products-Inspired Use of the gem-Dimethyl Group in Medicinal Chemistry
- (2017) Tanaji T. Talele JOURNAL OF MEDICINAL CHEMISTRY
- Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease
- (2017) Bitna Yi et al. JOURNAL OF NEUROCHEMISTRY
- Identification of the gene that codes for the σ2receptor
- (2017) Assaf Alon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Investigation of miscellaneous hERG inhibition in large diverse compound collection using automated patch-clamp assay
- (2016) Hai-bo Yu et al. ACTA PHARMACOLOGICA SINICA
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate
- (2016) Ting Yang et al. JOURNAL OF NEUROSCIENCE
- Prediction of hERG Liability - Using SVM Classification, Bootstrapping and Jackknifing
- (2016) Hongmao Sun et al. Molecular Informatics
- Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis
- (2015) Kirsten L. Viola et al. ACTA NEUROPATHOLOGICA
- Sigma-2 Receptor Ligands: Neurobiological Effects
- (2015) Lin Guo et al. CURRENT MEDICINAL CHEMISTRY
- Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease
- (2015) Sergio T. Ferreira et al. Frontiers in Cellular Neuroscience
- Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration
- (2015) Peng Liu et al. Cell Reports
- In Vivo Application of beta Amyloid Oligomers: A Simple Tool to Evaluate Mechanisms of Action and New Therapeutic Approaches
- (2015) Claudia Balducci et al. CURRENT PHARMACEUTICAL DESIGN
- Alzheimer's Disease-Like Pathology Induced by Amyloid-β Oligomers in Nonhuman Primates
- (2014) Leticia Forny-Germano et al. JOURNAL OF NEUROSCIENCE
- Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
- (2014) Nicholas J. Izzo et al. PLoS One
- Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits
- (2014) Nicholas J. Izzo et al. PLoS One
- Human LilrB2 Is a -Amyloid Receptor and Its Murine Homolog PirB Regulates Synaptic Plasticity in an Alzheimer's Model
- (2013) T. Kim et al. SCIENCE
- The case for soluble Aβ oligomers as a drug target in Alzheimer's disease
- (2013) Franz Hefti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Sigma-2 ligands induce tumour cell death by multiple signalling pathways
- (2012) C Zeng et al. BRITISH JOURNAL OF CANCER
- Thy1-hAPPLond/Swe+mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social function
- (2012) Mehrdad Faizi et al. Brain and Behavior
- Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site
- (2011) Jinbin Xu et al. Nature Communications
- Minocycline Recovers MTT-Formazan Exocytosis Impaired by Amyloid Beta Peptide
- (2010) Peter Kreutzmann et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Synthesis and Applications oftert-Butanesulfinamide
- (2010) MaryAnn T. Robak et al. CHEMICAL REVIEWS
- Picomolar Amyloid- Positively Modulates Synaptic Plasticity and Memory in Hippocampus
- (2009) D. Puzzo et al. JOURNAL OF NEUROSCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More